Asia Pacific Biochip Market Size & Outlook, 2023-2030
Asia Pacific biochip market, 2018-2030 (US$M)
Related Markets
Asia Pacific biochip market highlights
- The Asia Pacific biochip market generated a revenue of USD 1,542.2 million in 2023.
- The market is expected to grow at a CAGR of 14.4% from 2024 to 2030.
- In terms of segment, dna chips was the largest revenue generating type in 2023.
- Lab-on-chip is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 1,542.2 million |
| Market revenue in 2030 | USD 3,957.0 million |
| Growth rate | 14.4% (CAGR from 2023 to 2030) |
| Largest segment | Dna chips |
| Fastest growing segment | Lab-on-chip |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tissue Arrays, Cell Arrays, DNA Chips, Lab-on-chip, Protein Chips |
| Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 13.7% of the global biochip market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,957.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biochip Market Scope
Biochip Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific biochip market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 38.06% in 2023. Horizon Databook has segmented the Asia Pacific biochip market based on tissue arrays, cell arrays, dna chips, lab-on-chip, protein chips covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific region is estimated to register the fastest growth rate during the projected period. The fastpaced growth of this region is expected to be mainly driven by China and India. Key factors driving the industry growth include increase in access to technologies, a large patient pool, and improvement in healthcare infrastructure.
The increasing adoption of biochip technology in emerging markets by mature players to refine processes is also a significant factor driving the region’s growth. Moreover, the flourishing biotechnology sector, presence of a large number of research & academic institutes, and significant investments by market participants are projected to drive the region’s market.
Reasons to subscribe to Asia Pacific biochip market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific biochip market databook
-
Our clientele includes a mix of biochip market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific biochip market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific biochips market size, by country, 2018-2030 (US$M)
Asia Pacific Biochip Market Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
